Log In
Print
BCIQ
Print
Print this Print this
 

Minirinmelt, desmopressin (Minirin)

  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
DescriptionPeptide-based synthetic analogue of vasopressin
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationIncontinence
Indication DetailsTreat bedwetting; Treat primary nocturnal enuresis (PNE) in children
Regulatory Designation
Partner Kyowa Hakko Kirin Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today